Annexin A2 complexes with S100 proteins: Structure, function and pharmacological manipulation

British Journal of Pharmacology

Volumn 172, Issue 7, 2015, Pages 1664-1676

  Liu, Yidong ^a   Myrvang, Helene K ^a   Dekker, Lodewijk V ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT; CALCYCLIN; CALVASCULIN; CYCLIC AMP; FORSKOLIN; HEPARIN; HISTAMINE; KETOCONAZOLE; LIPOCORTIN 2; MEROCYANINE; OXYCLOZANIDE; PLASMINOGEN; PROTEIN INHIBITOR; PROTEIN KINASE C; PROTEIN S 100; PROTEIN S 100A10; PROTEIN S 100A11; PROTEIN TYROSINE KINASE; TISSUE PLASMINOGEN ACTIVATOR; TOLL LIKE RECEPTOR 4; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; S100 CALCIUM BINDING PROTEIN A10;

AMINO TERMINAL SEQUENCE; CALCIUM BINDING; CATALYSIS; HUMAN; HYDROPHOBICITY; IMMUNOPRECIPITATION; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; X RAY CRYSTALLOGRAPHY; ANIMAL; CHEMISTRY; METABOLISM;

ANIMALS; ANNEXIN A2; HUMANS; PROTEIN CONFORMATION; S100 PROTEINS;

EID: 84924873153     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12978     Document Type: Review

References (129)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Catalytic receptors. Br J Pharmacol 170: 1676-1705.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
3. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. (2007). Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13: 1050-1059.
4. Becker T, Weber K, Johnsson N, (1990). Protein-protein recognition via short amphiphilic helixes; a mutational analysis of the binding site of annexin II for p11. EMBO J 9: 4207-4213.
5. Bharadwaj A, Bydoun M, Holloway R, Waisman D, (2013). Annexin A2 heterotetramer: structure and function. Int J Mol Sci 14: 6259-6305.
6. Bjork P, Bjork A, Vogl T, Stenstrom M, Liberg D, Olsson A, et al. (2009). Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol 7: 800-812.
7. Bjork P, Kallberg E, Wellmar U, Riva M, Olsson A, He Z, et al. (2013). Common interactions between S100A4 and S100A9 defined by a novel chemical probe. PLoS ONE 8: e63012.
8. Borthwick LA, McGaw J, Conner G, Taylor CJ, Gerke V, Mehta A, et al. (2007). The formation of the cAMP/protein kinase A-dependent annexin 2-S100A10 complex with cystic fibrosis conductance regulator protein (CFTR) regulates CFTR channel function. Mol Biol Cell 18: 3388-3397.
9. Brandherm I, Disse J, Zeuschner D, Gerke V, (2013). cAMP-induced secretion of endothelial von Willebrand factor is regulated by a phosphorylation/dephosphorylation switch in annexin A2. Blood 122: 1042-1051.
10. Cesarman GM, Guevara CA, Hajjar KA, (1994). An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 269: 21198-21203.
11. Chasserot-Golaz S, Vitale N, Umbrecht-Jenck E, Knight D, Gerke V, Bader MF, (2005). Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of dense-core vesicles. Mol Biol Cell 16: 1108-1119.
12. Chiang YP, Davis RG, Vishwanatha JK, (1996). Altered expression of annexin II in human B-cell lymphoma cell lines. Biochim Biophys Acta 1313: 295-301.
13. Cross SS, Hamdy FC, Deloulme JC, Rehman I, (2005). Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46: 256-269.
14. Dassah M, Almeida D, Hahn R, Bonaldo P, Worgall S, Hajjar KA, (2014). Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells. J Cell Sci 127 (Pt 4): 828-844.
15. Davies BR, O'Donnell M, Durkan GC, Rudland PS, Barraclough R, Neal DE, et al. (2002). Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J Pathol 196: 292-299.
16. De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, et al. (2009). Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. Lung Cancer 63: 410-417.
17. De Seranno S, Benaud C, Assard N, Khediri S, Gerke V, Baudier J, et al. (2006). Identification of an AHNAK binding motif specific for the Annexin2/S100A10 tetramer. J Biol Chem 281: 35030-35038.
18. Debauve G, Capouillez A, Belayew A, Saussez S, (2008). The helicase-like transcription factor and its implication in cancer progression. Cell Mol Life Sci 65: 591-604.
19. Deora AB, Kreitzer G, Jacovina AT, Hajjar KA, (2004). An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem 279: 43411-43418.
20. Diaz VM, Hurtado M, Thomson TM, Reventos J, Paciucci R, (2004). Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 53: 993-1000.
21. Donato R, (1999). Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1450: 191-231.
22. Donato R, (2003). Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60: 540-551.
23. Drucker P, Pejic M, Galla HJ, Gerke V, (2013). Lipid segregation and membrane budding induced by the peripheral membrane binding protein annexin A2. J Biol Chem 288: 24764-24776.
24. Duda T, Goraczniak RM, Sharma RK, (1996). Molecular characterization of S100A1-S100B protein in retina and its activation mechanism of bovine photoreceptor guanylate cyclase. Biochemistry 35: 6263-6266.
25. Eberhard DA, Karns LR, VandenBerg SR, Creutz CE, (2001). Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J Cell Sci 114 (Pt 17): 3155-3166.
26. Erikson E, Tomasiewicz HG, Erikson RL, (1984). Biochemical characterization of a 34-kilodalton normal cellular substrate of pp60v-src and an associated 6-kilodalton protein. Mol Cell Biol 4: 77-85.
27. Fan X, Krahling S, Smith D, Williamson P, Schlegel RA, (2004). Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes. Mol Biol Cell 15: 2863-2872.
28. Fang YT, Lin CF, Wang CY, Anderson R, Lin YS, (2012). Interferon-gamma stimulates p11-dependent surface expression of annexin A2 in lung epithelial cells to enhance phagocytosis. J Cell Physiol 227: 2775-2787.
29. Filipek A, Wojda U, Lesniak W, (1995). Interaction of calcyclin and its cyanogen-bromide fragments with Annexin-II and Glyceraldehyde-3-Phosphate Dehydrogenase. Int J Biochem Cell Biol 27: 1123-1131.
30. Filipenko NR, Waisman DM, (2001). The C terminus of annexin II mediates binding to F-actin. J Biol Chem 276: 5310-5315.
31. Flood EC, Hajjar KA, (2011). The annexin A2 system and vascular homeostasis. Vascul Pharmacol 54: 59-67.
32. Foell D, Roth J, (2004). Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 50: 3762-3771.
33. Foulkes T, Nassar MA, Lane T, Matthews EA, Baker MD, Gerke V, et al. (2006). Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behavior. J Neurosci 26: 10499-10507.
34. Gandhi L, Camidge DR, Ribeiro de Oliveira M, Bonomi P, Gandara D, Khaira D, et al. (2011). Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors. J Clin Oncol 29: 909-916.
35. Garrett SC, Hodgson L, Rybin A, Toutchkine A, Hahn KM, Lawrence DS, et al. (2008). A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics. Biochemistry 47: 986-996.
36. Gebhardt C, Riehl A, Durchdewald M, Nemeth J, Fuerstenberger G, Mueller-Decker K, et al. (2008). RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 205: 275-285.
37. Gerke V, Moss SE, (2002). Annexins: from structure to function. Physiol Rev 82: 331-371.
38. Gerke V, Weber K, (1985a). Calcium-dependent conformational-changes in the 36-kda subunit of intestinal protein-I related to the cellular 36-kDa target of Rous sarcoma virus tyrosine kinase. J Biol Chem 260: 1688-1695.
39. Gerke V, Weber K, (1985b). The regulatory chain in the p36-kD substrate complex of viral tyrosine-specific protein-kinases is related in sequence to the S-100 protein of glial-cells. EMBO J 4: 2917-2920.
40. Gerke V, Creutz CE, Moss SE, (2005). Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461.
41. Glenney JR Jr, Boudreau M, Galyean R, Hunter T, Tack B, (1986). Association of the S-100-related calpactin I light chain with the NH2-terminal tail of the 36-kDa heavy chain. J Biol Chem 261: 10485-10488.
42. Gould KL, Woodgett JR, Isacke CM, Hunter T, (1986). The protein-tyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo. Mol Cell Biol 6: 2738-2744.
43. Grindheim AK, Hollas H, Ramirez J, Saraste J, Trave G, Vedeler A, (2014). Effect of serine phosphorylation and ser25 phospho-mimicking mutations on nuclear localisation and ligand interactions of annexin A2. J Mol Biol 426: 2486-2499.
44. Hajjar KA, Jacovina AT, Chacko J, (1994). An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269: 21191-21197.
45. Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, et al. (1998). Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J Biol Chem 273: 9987-9993.
46. Hamberg AP, Korse CM, Bonfrer JMG, de Gast GC, (2003). Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma. Melanoma Res 13: 45-49.
47. Harder T, Gerke V, (1994). The annexin II2p11(2) complex is the major protein component of the triton X-100-insoluble low-density fraction prepared from MDCK cells in the presence of Ca2. Biochim Biophys Acta 1223: 375-382.
48. Hayes MJ, Rescher U, Gerke V, Moss SE, (2004). Annexin-actin interactions. Traffic 5: 571-576.
49. Hayes MJ, Shao D, Bailly M, Moss SE, (2006). Regulation of actin dynamics by annexin 2. EMBO J 25: 1816-1826.
50. He K-L, Deora AB, Xiong H, Ling Q, Weksler BB, Niesvizky R, et al. (2008). Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J Biol Chem 283: 19192-19200.
51. Huang B, Deora AB, He KL, Chen K, Sui G, Jacovina AT, et al. (2011). Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood 118: 2918-2929.
52. Huang Y, Laval SH, van Remoortere A, Baudier J, Benaud C, Anderson LVB, et al. (2007). AHNAR, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J 21: 732-742.
53. Ikebuchi NW, Waisman DM, (1990). Calcium-dependent regulation of actin filament bundling by lipocortin-85. J Biol Chem 265: 3392-3400.
54. Illien F, Finet S, Lambert O, Ayala-Sanmartin J, (2010). Different molecular arrangements of the tetrameric annexin 2 modulate the size and dynamics of membrane aggregation. Biochim Biophys Acta 1798: 1790-1796.
55. Jaiswal JK, Lauritzen SP, Scheffer L, Sakaguchi M, Bunkenborg J, Simon SM, et al. (2014). S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells. Nat Commun 5: 3795.
56. Johnsson N, Vandekerckhove J, Van Damme J, Weber K, (1986). Binding sites for calcium, lipid and p11 on p36, the substrate of retroviral tyrosine-specific protein kinases. FEBS Lett 198: 361-364.
57. Johnsson N, Marriott G, Weber K, (1988). p36, the major cytoplasmic substrate of src tyrosine protein-kinase, binds to its p11 regulatory subunit via a short amino-terminal amphiphatic helix. EMBO J 7: 2435-2442.
58. Jones PG, Moore GJ, Waisman DM, (1992). A nonapeptide to the putative F-actin binding site of annexin-II tetramer inhibits its calcium-dependent activation of actin filament bundling. J Biol Chem 267: 13993-13997.
59. Jost M, Gerke V, (1996). Mapping of a regulatory important site for protein kinase C phosphorylation in the N-terminal domain of annexin II. Biochim Biophys Acta 1313: 283-289.
60. Jung Y, Wang J, Song J, Shiozawa Y, Wang J, Havens A, et al. (2007). Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood 110: 82-90.
61. Kassam G, Le BH, Choi KS, Kang HM, Fitzpatrick SL, Louie P, et al. (1998). The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation. Biochemistry 37: 16958-16966.
62. Khanna NC, Tokuda M, Chong SM, Waisman DM, (1986). Phosphorylation of p36 in vitro by protein kinase C. Biochem Biophys Res Commun 137: 397-403.
63. Knop M, Aareskjold E, Bode G, Gerke V, (2004). Rab3D and annexin A2 play a role in regulated secretion of vWF, but not tPA, from endothelial cells. EMBO J 23: 2982-2992.
64. Konig J, Prenen J, Nilius B, Gerke V, (1998). The annexin II-p11 complex is involved in regulated exocytosis in bovine pulmonary artery endothelial cells. J Biol Chem 273: 19679-19684.
65. Kube E, Becker T, Weber K, Gerke V, (1992). Protein-protein interaction studied by site-directed mutagenesis. Characterization of the annexin II-binding site on p11, a member of the S100 protein family. J Biol Chem 267: 14175-14182.
66. Kwon M, MacLeod TJ, Zhang Y, Waisman DM, (2005). S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front Biosci 10: 300-325.
67. Lambert O, Gerke V, Bader MF, Porte F, Brisson A, (1997). Structural analysis of junctions formed between lipid membranes and several annexins by cryo-electron microscopy. J Mol Biol 272: 42-55.
68. Lambert O, Cavusoglu N, Gallay J, Vincent M, Rigaud JL, Henry JP, et al. (2004). Novel organization and properties of annexin 2-membrane complexes. J Biol Chem 279: 10872-10882.
69. Law AL, Ling Q, Hajjar KA, Futter CE, Greenwood J, Adamson P, et al. (2009). Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. Mol Biol Cell 20: 3896-3904.
70. Lee DB, Jamgotchian N, Allen SG, Kan FW, Hale IL, (2004). Annexin A2 heterotetramer: role in tight junction assembly. Am J Physiol Renal Physiol 287: F481-F491.
71. Lee DB, Jamgotchian N, Allen SG, Abeles MB, Ward HJ, (2008). A lipid-protein hybrid model for tight junction. Am J Physiol Renal Physiol 295: F1601-F1612.
72. Leffler J, Herbert AP, Norstrom E, Schmidt CQ, Barlow PN, Blom AM, et al. (2010). Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells. J Biol Chem 285: 3766-3776.
73. Li C, Reddy TRK, Fischer PM, Dekker LV, (2010). A Cy5-labelled S100A10 tracer used to identify inhibitors of the protein interaction with annexin A2. Assay Drug Dev Technol 8: 85-95.
74. Ling Q, Jacovina AT, Deora A, Febbraio M, Simantov R, Silverstein RL, et al. (2004). Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest 113: 38-48.
75. Lipinski CA, (2004). Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1: 337-341.
76. Liu J, Rothermund Christy A, Ayala-Sanmartin J, Vishwanatha Jamboor K, (2003). Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II. BMC Biochem 4: 10.
77. Luo M, Hajjar KA, (2013). Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost 39: 338-346.
78. MacLeod TJ, Kwon M, Filipenko NR, Waisman DM, (2003). Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J Biol Chem 278: 25577-25584.
79. Madureira PA, Surette AP, Phipps KD, Taboski MA, Miller VA, Waisman DM, (2011). The role of the annexin A2 heterotetramer in vascular fibrinolysis. Blood 118: 4789-4797.
80. Madureira PA, O'Connell PA, Surette AP, Miller VA, Waisman DM, (2012). The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis. J Biomed Biotechnol 2012: 353687.
81. Malashkevich VN, Varney KM, Garrett SC, Wilder PT, Knight D, Charpentier TH, et al. (2008). Structure of Ca2+-bound S100A4 and its interaction with peptides derived from nonmuscle myosin-IIA. Biochemistry 47: 5111-5126.
82. Malashkevich VN, Dulyaninova NG, Ramagopal UA, Liriano MA, Varney KM, Knight D, et al. (2010). Phenothiazines inhibit S100A4 function by inducing protein oligomerization. Proc Natl Acad Sci U S A 107: 8605-8610.
83. Martin M, Leffler J, Blom AM, (2012). Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J Biol Chem 287: 33733-33744.
84. Menke M, Ross M, Gerke V, Steinem C, (2004). The molecular arrangement of membrane-bound annexin A2-S100A10 tetramer as revealed by scanning force microscopy. Chembiochem 5: 1003-1006.
85. Monastyrskaya K, Babiychuk EB, Hostettler A, Rescher U, Draeger A, (2007). Annexins as intracellular calcium sensors. Cell Calcium 41: 207-219.
86. Monastyrskaya K, Tschumi F, Babiychuk EB, Stroka D, Draeger A, (2008). Annexins sense changes in intracellular pH during hypoxia. Biochem J 409: 65-75.
87. Munz B, Gerke V, Gillitzer R, Werner S, (1997). Differential expression of the calpactin I subunits annexin II and p11 in cultured keratinocytes and during wound repair. J Invest Dermatol 108: 307-312.
88. Myrvang HK, Guo X, Li C, Dekker LV, (2013). Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells. FEBS Lett 587: 3210-3215.
89. Nazmi AR, Ozorowski G, Pejic M, Whitelegge JP, Gerke V, Luecke H, (2012). N-terminal acetylation of annexin A2 is required for S100A10 binding. Biol Chem 393: 1141-1150.
90. Nedjadi T, Kitteringham N, Campbell F, Jenkins RE, Park BK, Navarro P, et al. (2009). S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility. Br J Cancer 101: 1145-1154.
91. Nilius B, Gerke V, Prenen J, Szucs G, Heinke S, Weber K, et al. (1996). Annexin II modulates volume-activated chloride currents in vascular endothelial cells. J Biol Chem 271: 30631-30636.
92. O'Connell PA, Surette AP, Liwski RS, Svenningsson P, Waisman DM, (2010). S100A10 regulates plasminogen-dependent macrophage invasion. Blood 116: 1136-1146.
93. Odink K, Cerletti N, Bruggen J, Clerc RG, Tarcsay L, Zwadlo G, et al. (1987). 2 calcium-binding proteins in infiltrate macrophages of rheumatoid-arthritis. Nature 330: 80-82.
94. Oh Y-S, Gao P, Lee K-W, Ceglia I, Seo J-S, Zhang X, et al. (2013). SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. Cell 152: 831-843.
95. Ozorowski G, Ryan CM, Whitelegge JP, Luecke H, (2012). Withaferin A binds covalently to the N-terminal domain of annexin A2. Biol Chem 393: 1151-1163.
96. Ozorowski G, Milton S, Luecke H, (2013). Structure of a C-terminal AHNAK peptide in a 1:2:2 complex with S100A10 and an acetylated N-terminal peptide of annexin A2. Acta Crystallogr D Biol Crystallogr 69: 92-104.
97. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
98. Phipps KD, Surette AP, O'Connell PA, Waisman DM, (2011). Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites. Cancer Res 71: 6676-6683.
99. Powell MA, Glenney JR, (1987). Regulation of calpactin I phospholipid binding by calpactin I light-chain binding and phosphorylation by p60v-src. Biochem J 247: 321-328.
100. Puisieux A, Ji J, Ozturk M, (1996). Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanism. Biochem J 313: 51-55.
101. Reddy TR, Li C, Guo X, Fischer PM, Dekker LV, (2014). Design, synthesis and SAR exploration of tri-substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction. Bioorg Med Chem 22: 5378-5391.
102. Reddy TRK, Li C, Guo X, Myrvang HK, Fischer PM, Dekker LV, (2011). Design, synthesis, and structure-activity relationship exploration of 1-substituted 4-aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one analogues as inhibitors of the annexin A2-S100A10 protein interaction. J Med Chem 54: 2080-2094.
103. Reddy TRK, Li C, Fischer PM, Dekker LV, (2012). Three-dimensional pharmacophore design and biochemical screening identifies substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction. ChemMedChem 7: 1435-1446.
104. Regnouf F, Rendon A, Pradel LA, (1991). Biochemical characterization of annexins I and II isolated from pig nervous tissue. J Neurochem 56: 1985-1996.
105. Regnouf F, Sagot I, Delouche B, Devilliers G, Cartaud J, Henry JP, et al. (1995). In vitro' phosphorylation of annexin 2 heterotetramer by protein kinase C. Comparative properties of the unphosphorylated and phosphorylated annexin 2 on the aggregation and fusion of chromaffin granule membranes. J Biol Chem 270: 27143-27150.
106. Rescher U, Gerke V, (2004). Annexins-unique membrane binding proteins with diverse functions. J Cell Sci 117: 2631-2639.
107. Rety S, Sopkova J, Renouard M, Osterloh D, Gerke V, Tabaries S, et al. (1999). The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat Struct Biol 6: 89-95.
108. Rezvanpour A, Santamaria-Kisiel L, Shaw GS, (2011). The S100A10-annexin A2 complex provides a novel asymmetric platform for membrane repair. J Biol Chem 286: 40174-40183.
109. Rintala-Dempsey AC, Santamaria-Kisiel L, Liao Y, Lajoie G, Shaw GS, (2006). Insights into S100 target specificity examined by a new interaction between S100A11 and annexin A2. Biochemistry 45: 14695-14705.
110. Schlagenhauff B, Schittek B, Ellwanger U, Stroebel W, Blum A, Schwarz M, et al. (2000). Significance of serum protein S100 levels in screening for melanoma metastasis: does protein S100 enable early detection of melanoma recurrence? Melanoma Res 10: 451-459.
111. Semov A, Moreno MJ, Onichtchenko A, Abulrob A, Ball M, Ekiel I, et al. (2005). Metastasis-associated protein S100A4 induces angiogenesis through interaction with annexin II and accelerated plasmin formation. J Biol Chem 280: 20833-20841.
112. Shangary S, Wang S, (2008). Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res 14: 5318-5324.
113. Shangary S, Wang S, (2009). Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy. Annu Rev Pharmacol Toxicol 49: 223-241.
114. Shiozawa Y, Havens AM, Jung Y, Ziegler AM, Pedersen EA, Wang J, et al. (2008). Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem 105: 370-380.
115. Shtivelman E, Cohen FE, Bishop JM, (1992). A human gene (AHNAK) encoding an unusually large protein with a 1.2-mu-m polyionic rod structure. Proc Natl Acad Sci U S A 89: 5472-5476.
116. Sopkova-de Oliveira Santos J, Oling FK, Rety S, Brisson A, Smith JC, Lewit-Bentley A, (2000). S100 protein-annexin interactions: a model of the (Anx2-p11) (2) heterotetramer complex. Biochim Biophys Acta 1498: 181-191.
117. Streicher WW, Lopez MM, Makhatadze GI, (2009). Annexin I and annexin II N-terminal peptides binding to S100 protein family members: specificity and thermodynamic characterization. Biochemistry 48: 2788-2798.
118. Surette AP, Madureira PA, Phipps KD, Miller VA, Svenningsson P, Waisman DM, (2011). Regulation of fibrinolysis by S100A10 in vivo. Blood 118: 3172-3181.
119. Tarabykina S, Kriajevska M, Scott DJ, Hill TJ, Lafitte D, Derrick PJ, et al. (2000). Heterocomplex formation between metastasis-related protein S100A4 (Mts1) and S100A1 as revealed by the yeast two-hybrid system. FEBS Lett 475: 187-191.
120. Thiel C, Osborn M, Gerke V, (1992). The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11- and Ca(2+)-binding sites. J Cell Sci 103 (Pt 3): 733-742.
121. Tsuna M, Kageyama S-I, Fukuoka J, Kitano H, Doki Y, Tezuka H, et al. (2009). Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma. Anticancer Res 29: 2547-2554.
122. Umbrecht-Jenck E, Demais V, Calco V, Bailly Y, Bader MF, Chasserot-Golaz S, (2010). S100A10-mediated translocation of annexin-A2 to SNARE proteins in adrenergic chromaffin cells undergoing exocytosis. Traffic 11: 958-971.
123. Vimalachandran D, Greenhalf W, Thompson C, Luttges J, Prime W, Campbell F, et al. (2005). High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res 65: 3218-3225.
124. Waisman DM, (1995). Annexin II tetramer: structure and function. Mol Cell Biochem 149-150: 301-322.
125. Wang GZ, Zhang S, Fernig DG, Spiller D, Martin-Fernandez M, Zhang HM, et al. (2004). Heterodimeric interaction and interfaces of S100A1 and S100P. Biochem J 382: 375-383.
126. Yammani RR, Carlson CS, Bresnick AR, Loeser RF, (2006). Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4-role of the receptor for advanced glycation end products. Arthritis Rheum 54: 2901-2911.
127. Zeng FY, Gerke V, Gabius HJ, (1993). Identification of Annexin-II, Annexin-VI and Glyceraldehyde-3-Phosphate Dehydrogenase as Calcyclin-binding proteins in bovine heart. Int J Biochem 25: 1019-1027.
128. Zhang ZQ, Wietgrefe SW, Li QS, Shore MD, Duan LJ, Reilly C, et al. (2004). Roles of substrate availability and infection of restina and activated CD4(+) T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci U S A 101: 5640-5645.
129. Zobiack N, Gerke V, Rescher U, (2001). Complex formation and submembranous localization of annexin 2 and S100A10 in live HepG2 cells. FEBS Lett 500: 137-140.